2015-01-28 - Male - 32 Years old
900233833
| Adverse reaction report number | 900233833 |
| Latest AER version number | 0 |
| Market authorization holder AER number | CA201500520 |
| Initial received date | 2015-01-28 |
| Latest received date | 2015-01-28 |
| Age | 32 Years |
| Gender | Male |
| Weight | N/A |
| Type of report | Spontaneous |
| Reporter type | Consumer Or Other Non Health Professional |
| Source of report | MAH |
| Report outcome | Recovered/resolved |
| Serious report? | No |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR | Suspect | Oral | 15 Milligram | Attention deficit/hyperactivity disorder | |||
| ADDERALL XR | Suspect | Oral | 20 Milligram | Attention deficit/hyperactivity disorder | |||
| ADDERALL XR | Suspect | Oral | 30 Milligram | Attention deficit/hyperactivity disorder | |||
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 10 Milligram | Attention deficit/hyperactivity disorder |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Prescribed overdose | |
| Therapeutic response shortened | |
| Unevaluable event | |